AVE 0.00% 0.2¢ avecho biotechnology limited

Ann: Appendix 4E and Annual Report 31 December 2021, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 300 Posts.
    lightbulb Created with Sketch. 3
    Extracts from various sections of the Annual Report are interesting. Neither Team SAAS or AVE would make such positive decisions if they did not believe the distillate will be a winner.

    "On 2 February 2022, the Company announced it has entered into a product license and supply agreement (Agreement) with
    Team SAAS LLC (SAAS) granting SAAS exclusive rights to commercialise a recreational cannabis distillate containing TPM®
    for use in the manufacture of edible cannabis products in the US.

    The Company will receive a licence fee calculated by reference to SAAS’ net profits after tax. The Company will receive 50%
    of SAAS’ net profit after tax on net sales of the product, which will be paid quarterly. SAAS must pay a minimum licence fee
    of US$1M (A$1.38 Million) within the first 12 months, US$2.5m (A$3.45 Million) within the first 2 years and US$5 (A$6.9 million) within the first 4 years.

    https://hotcopper.com.au/data/attachments/4125/4125266-3668d3e91deb4dae9a56f6f675b6cc7e.jpg

    https://hotcopper.com.au/data/attachments/4125/4125269-a351f96a5bbb5cd30c0eed0122d04702.jpg"







 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $540 270K

Buyers (Bids)

No. Vol. Price($)
17 13918600 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41116983 27
View Market Depth
Last trade - 10.35am 05/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.